ArticleTranslational cancer research2025

Efficacy, safety and cost-effectiveness of chemo-immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: an updated systematic review and cost-effectiveness analysis.

Lei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.